Astellas Pharma Inc: Candidiasis trials

The registry lists 14 Candidiasis studies with Astellas Pharma Inc as lead sponsor. 0 are open to participants now and 2 have results posted.

Phase 1 2Phase 2 3Phase 3 7Phase 4 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Study to Compare the Efficacy and Safety of Micafungin Versus Conventional Amphotericin B for the Treatment of Neonatal CandidiasisTerminatedNCT00815516Phase 3Results posted
• Isavuconazole (BAL8557) in the Treatment of Candidemia and Other Invasive Candida InfectionsCompletedNCT00413218Phase 3Results posted
• Determination of Levels of Micafungin in Neonates Suffering From Systemic Candidiasis and/or Candida MeningitisCompletedNCT03421002Phase 2
• Post Marketing Study to Evaluate the Safety and Efficacy of Micafungin Against Fungal Infections Caused by Candida Spp or Aspergillus SppTerminatedNCT02646800Phase 4
• A Study to Evaluate the Efficacy and Safety of Micafungin Against Invasive Candidiasis or CandidemiaTerminatedNCT01982071Phase 4
• A Study to Evaluate Pre-emptive Treatment for Invasive Candidiasis in High Risk Surgical SubjectsCompletedNCT01122368Phase 2
• Comparative Trial of Micafungin Versus Fluconazole for Treating Esophageal CandidiasisCompletedNCT00666185Phase 3
• Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal CandidiasisCompletedNCT00665639Phase 3
• Study of Mycamine® in Children With Fungal Infections to Evaluate Safety and Blood Levels of the DrugCompletedNCT00608335Phase 1
• Study of Mycamine® in Infants and Toddlers With Fungal Infections to Evaluate Safety and Blood Levels of the DrugCompletedNCT00607763Phase 1
• Micafungin Versus Fluconazole in the Treatment of Invasive Candidiasis and CandidemiaCompletedNCT00189709Phase 3
• Micafungin Versus AmBisome in Invasive Candidiasis and CandidemiaCompletedNCT00106288Phase 3
• Study of Micafungin in Patients With Invasive Candidiasis or CandidemiaCompletedNCT00105144Phase 3
• Study of FK463 in the Treatment of Candidemia or Invasive CandidiasisCompletedNCT00036179Phase 2